June 25th, 2011
Podcast 124: Getting more accuracy into blood pressure measurements
Patients’ systolic pressures vary by about 10%, regardless of whether they are measured at home or under the duress of a visit to the doctor. That variation is troubling when deciding whether to put a patient on an antihypertensive regimen: how reliable are the measurements that will form the basis of your decision? How do […]
May 6th, 2011
Podcast 120: Pass the salt!
European researchers say they’ve got the data to show that restricting salt in the general population is a bad mistake. By implication, the U.S. dietary salt guidelines are plainly wrong. How did they do this? They followed 3700 subjects for roughly 8 years, having first measured their 24-hour urinary sodium excretion. Their data show that lower […]
November 19th, 2010
Podcast 109: An overview of the American Heart Association meeting, with cardiologist Harlan Krumholz
We’ve got Dr. Harlan Krumholz, editor of Journal Watch Cardiology and CardioExchange, to guide us through a week’s worth of the top research presented at the American Heart Association in Chicago. Interview-related links (in the order we discuss them in the interview): CardioExchange (worth checking out — it’s an experiment in the clinical use of social media) […]
November 2nd, 2010
Podcast 106: The barbershop and hypertension — a little off the top
OK, now what can be done to control hypertension among African American men? What about recruiting barbershops to put a shoulder to the wheel? They’re community centers, trusted sources of gossip and advice, and places of relaxation. In Texas, a group of researchers undertook a randomized trial in black-owned barbershops in which barbers took blood […]
July 9th, 2010
Podcast 95: What if hypertensive patients titrated their own drug dosages?
This week’s interview is with the editorialist commenting on an exciting Lancet paper. The writer, Dr. Gbenga Ogedegbe, says that the work, in which patients with uncontrolled hypertension titrated their own medications according to prespecified rules, could change how clinicians manage uncomplicated hypertension. From his base at New York University School of Medicine, Dr. Ogedegbe […]
February 19th, 2010
Podcast 75: Which regimen for hypertension?
Patients with hypertension at risk for cardiovascular events have done better with an ACE inhibitor-calcium channel blocker combination than with the ACE inhibitor plus hydrochlorothiazide. The ACCOMPLISH investigators have now reported on their analysis of progression-of-nephropathy outcomes in their trial. We interview the first author of the analysis, Dr. George Bakris of the University of […]